Rather & Kittrell’s Merck MRK Stock Holding History

Rather & Kittrell’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-147	Closed	-$11K	–	213
2021 Q4	$11K	Buy	+147	New	+$11.7K	0.01%	218

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Rather & Kittrell's MRK Position: Q1 2022 in Review

Rather & Kittrell sold out of Merck (MRK) in Q1 2022, closing a stake of 147 shares — an estimated $11K sold.

Rather & Kittrell first reported a position in MRK in Q4 2021 and held it in 1 quarter. The position peaked at $11K in Q4 2021. 2,952 funds tracked by Wall St. Rank hold MRK as of Q1 2022.

Rather & Kittrell reported no remaining Merck position as of Q1 2022 after selling out during the quarter.
Rather & Kittrell sold 147 Merck shares in Q1 2022, an estimated $11K.
Rather & Kittrell first reported a position in Merck in Q4 2021 and held it in 1 quarter.
Rather & Kittrell's Merck position peaked at $11K in Q4 2021.
2,952 funds tracked by Wall St. Rank held Merck as of Q1 2022.

Based on Rather & Kittrell's 13F filing for Q1 2022, filed 10 May 2022.